Cadrenal Therapeutics shareholders approve equity plan amendment and warrant issuance

🌐 Investing.com (Cyprus) —
Cadrenal Therapeutics shareholders approve equity plan amendment and warrant issuance

AI Summary

Cadrenal Therapeutics shareholders approved an amendment to the company’s equity plan and the issuance of warrants. The report does not specify the financial terms or intended use of the proceeds.

Markets Deals Health Cadrenal Therapeutics shareholder vote equity plan warrants biotechnology

Read original source →